Surgical treatment of gastric cancer: Results in 423 cases Resultados del tratamiento quirúrgico del cáncer gástrico. Análisis de 423 casos
Author
dc.contributor.author
García C, Carlos
Author
dc.contributor.author
Benavides C, Carlos
Author
dc.contributor.author
Apablaza P, Sergio
Author
dc.contributor.author
Rubilar O, Patricio
Author
dc.contributor.author
Covacevich R, Sergio
Author
dc.contributor.author
Peñaloza M, Paulina
Author
dc.contributor.author
Guerra C, Juan
Author
dc.contributor.author
Horwitz Z, Benjamín
Author
dc.contributor.author
Domancic H, Paloma
Author
dc.contributor.author
Bustamante R, Miviala
Author
dc.contributor.author
Romero S, Carolina
Admission date
dc.date.accessioned
2019-03-11T12:54:15Z
Available date
dc.date.available
2019-03-11T12:54:15Z
Publication date
dc.date.issued
2007
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 135, Issue 6, 2018, Pages 687-695
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164375
Abstract
dc.description.abstract
Background: Gastric cancer is the second cause of cancer death worldwide and the first cause in Chile. Management of this pathology is controversial. Aim: To report the results on morbidity, mortality, and long-term survival rates of surgical treatment of gastric cancer, and compare them with those reported in the literature. Material and Methods: Follow up of 423 patients (aged 16 to 88 years, 271 males) operated for a gastric adenocarcinoma between 1996 and 2002. Patients were staged with the 5th edition of TNM staging system, and the 2nd edition in English of the Japanese Classification of Gastric Cancer. Morbidity was assessed using the classification of the Memorial Kettering Cancer Center group. Kapplan-Meier method was used to assay survival, and Log rank Test to compare long-term survivals. Results: Resectability of the lesions was 70.4%, and 88% of them corresponded to a curative-intended surgery. Seventy percent of patients were in stage TNM IIIA or higher at the moment of su